Printer Friendly

Browse Pharmaceutical industry topic

Analysis subtopic


1-228 out of 228 article(s)
Title Author Type Date Words
Eli Lilly meets primary and all key secondary endpoints in COAST-V study. Feb 15, 2018 185
Eli Lilly meets primary and all key secondary endpoints in COAST-V study. Feb 15, 2018 189
United States : Merck Announces Discontinuation of APECS Study Evaluating Verubecestat (MK-8931) for the Treatment of People with Prodromal Alzheimers Disease. Feb 14, 2018 186
Germany : Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium. Feb 8, 2018 479
Bristol-Myers Phase 3 study of Opdivo plus Yervoy shows superior survival. Feb 5, 2018 179
The Disease Burden of Atopic Dermatitis. Eichenfield, Lawrence F.; Gold, Linda F. Stein Dec 1, 2017 2909
Pharma firm issues caution on use of anti-dengue vaccine. Nov 30, 2017 525
Ireland : Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual Congress. Nov 2, 2017 362
Vical Inc. was advised by the FDA that its investigational antifungal VL 2397 would be eligible for a Limited Use Indication (LUI) approval assuming a successful outcome of a single Phase II trial conducted in accordance with a protocol and statistical analysis plan consistent with the Agency's advice. Nov 1, 2017 248
AF ablation topped drugs for improving quality of life. Zoler, Mitchel L. Oct 15, 2017 874
United States : New data shows astigmatism tends to worsen following cataract surgery with a standard monofocal IOL, while patient awareness about advanced technology treatment options is limited. Oct 11, 2017 651
United States : Six-year Efficacy Data for GARDASIL 9 Presented at EUROGIN 2017 Congress. Oct 11, 2017 594
New data shows astigmatism tends to worsen following cataract surgery with a standard monofocal IOL, while patient awareness about advanced technology treatment options is limited. Oct 10, 2017 1465
New data shows astigmatism tends to worsen following cataract surgery with a standard monofocal IOL, while patient awareness about advanced technology treatment options is limited. Oct 10, 2017 1491
Germany : Bayers NAVIGATE ESUS study halted early as it indicated comparable efficacy between treatment arms. Oct 6, 2017 416
Champions Oncology, AstraZeneca. Oct 1, 2017 286
Germany : AstraZeneca presents new results identifying severe asthma patients who would benefit most from benralizumab. Sep 12, 2017 453
United Kingdom : AstraZeneca presents new results identifying severe asthma patients who would benefit most from benralizumab. Sep 11, 2017 453
Switzerland : Novartis presents new analysis demonstrating AMG 334 (erenumab) significantly reduced monthly migraine days in patients who failed previous preventive therapies. Sep 8, 2017 254
Supply Of Spares Of Water Purification System, Make Merck Sas, France, Model Elix (03 Nos. And Milliq (01 No. Sep 6, 2017 121
Switzerland : Novartis announces analysis published in The Lancet showing ACZ885 reduced lung cancer mortality by 77% in the CANTOS study with further studies planned. Aug 28, 2017 589
Investment of financial resources for the procurement of medicines for primary care in Brazilian municipalities. Pontes, Marcela Amaral; Tavares, Noemia Uruth Leao; Francisco, Priscila Maria Stolses Bergamo; Naves Ensayo Aug 1, 2017 5958
A cross-sectional study on the prevalence of work-related musculoskeletal disorders in the dof pharmaceutical industry. Shah, Hardik R.; Bhatt, Parul; Vaghani, Binal D.; Vaghani, Jayul Report Aug 1, 2017 3214
Los medicamentos genericos en Colombia: industria, politicas de salud y farmaceutizacion durante la decada de 1960. Garcia, Victor Manuel Ensayo Jul 1, 2017 12673
Japan : Cardiovascular Outcomes Trial of Anti-obesity Agent Lorcaserin to Continue Based on Recommendation of Independent Data Monitoring Committee After Completion of Interim Safety Analysis. Jun 23, 2017 241
United States : AstraZeneca presents new data underpinning safety profile and real-world CV outcomes of Farxiga at ADA 2017. Jun 14, 2017 215
GW Pharmaceuticals reports positive trial results for cannabis-derived therapy Epidiolex. May 25, 2017 239
GW Pharmaceuticals reports positive trial results for cannabis-derived therapy Epidiolex. May 25, 2017 235
Switzerland : Novartis' new analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids. May 24, 2017 373
United States : Merck to Present New Phase 3 Data on Investigational Ertugliflozin, Additional Analyses of Studies of JANUVIA (sitagliptin), and Real-World Evidence Research at the 77th Scientific Sessions of the American Diabetes Association. May 17, 2017 182
United States : AstraZeneca provides update on STRATOS 1 Phase III trial of tralokinumab in severe, uncontrolled asthma. May 11, 2017 310
Sweden : Teva Announces Publication of COPAXONE (glatiramer acetate injection) Pregnancy Data in the International Journal of MS Care. May 8, 2017 387
Japan : Eisai Presents Data of Mechanisms of Action Relating to Tumor Immune Response Regarding Combination of Anticancer Agent Lenvatinib With Anti-pd-1 Antibody at Aacr 108th Annual Meeting. Apr 7, 2017 384
United States : Regeneron and Sanofi Announce Praluent (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis. Nov 18, 2016 171
Switzerland : New analysis of Novartis' Entresto data shows long-term benefits on heart failure readmissions and total cardiovascular deaths. Nov 17, 2016 495
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies Corporation (DVAX). Nov 14, 2016 423
The promise of effective RSV vaccines is on the horizon. Haelle, Tara Nov 1, 2016 766
United States : Mercks KEYNOTE-045 Studying KEYTRUDA in Advanced Bladder Cancer Meets Primary Endpoint and Stops Early. Oct 22, 2016 231
United States : Defining the true value of innovation in cancer treatment. Oct 21, 2016 370
United Kingdom : Innovative pancreatic research expands treatment horizons for people with type 2 diabetes. Sep 24, 2016 907
Switzerland : Important new analysis shows that Novartis' Entresto is associated with higher relative health-related quality of life scores among HFrEF patients. Sep 21, 2016 655
Japan : Eisai presents results of additional analysis of phase III study of anticancer agent Halaven at 14th JSMO annual meeting plenary session. Aug 3, 2016 490
United States : Pfizer Research advances Body of Evidence for Tofacitinib Citrate (XELJANZ) providing Clinicians with additional Information for the Treatment of Moderate to severe RA. Jun 10, 2016 253
Switzerland : Novartis presents new scientific evidence for Cosentyx in ankylosing spondylitis and psoriatic arthritis patients at EULAR 2016. Jun 9, 2016 312
Janssen Expands Body of Evidence for INVOKANA (canagliflozin) with 18 New Data Presentations at American Diabetes Association's 76th Scientific Sessions. Jun 6, 2016 2931
United States : Regeneron and Sanofi Genzyme to present additional data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society Internation. Report May 12, 2016 234
Supply of lab chemicals for boiler & feed water analysis. Apr 25, 2016 252
Switzerland : New analyses show Novartis Entresto(TM) reduced cardiovascular death or hospitalization for heart failure, consistently benefitting patients with reduced ejection fraction regardless. Apr 5, 2016 683
Specialty Pharmacy Providers & Specialty Pharmaceutical Manufacturers - An Evolving Partnership. Mar 24, 2016 557
OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023. Mar 10, 2016 502
Germany : New Analyses Further Add to the Efficacy and Safety Profile of OFEVA (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF). Nov 16, 2015 928
Switzerland : Long-term efficacy of Gilenya reinforced by new 'no evidence of disease activity'(NEDA-4) analysis in MS patients over seven years. Oct 9, 2015 354
Impedance spectroscopy of polymer electrolytes based on epoxidized natural rubber with 50 mol% epoxide content. Chan, Chin Han; Kammer, Hans-Werner Oct 1, 2015 4079
PHARMASOILS: Fate and effects of Pharmaceuticals in Soil-Plants System. Jul 6, 2015 219
Determination of surface energies and acidity-basicity numbers of protonated and deprotonated forms of poly(sulfonic acid diphenyl aniline) by inverse gas chromatography. Yazici, Ozlem; Karaman, Ferdane Jun 1, 2015 7475
New Data Show Proleukin (aldesleukin) Improves Patient Outcomes as First-Line Therapy for the Treatment of Patients with Metastatic Melanoma or Metastatic Renal Cell Carcinoma. Clinical report May 15, 2015 1526
Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent(TM) (alirocumab) Published in The New England Journal of Medicine. Mar 15, 2015 2632
Can-Fite's CF602 Demonstrates Efficacy in Treatment of Sexual Dysfunction in Preclinical Studies. Jan 27, 2015 963
The opportunity cost of capital: Development of new pharmaceuticals. Chit, Ayman; Chit, Ahmad; Papadimitropoulos, Manny; Krahn, Murray; Parker, Jayson; Grootendorst, Pau Statistical data Jan 1, 2015 3646
InformationWeek: 5 Big Data Trends You Missed in 2014. Dec 10, 2014 660
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma. Clinical report Nov 11, 2014 2420
LCZ696 in study for HF with preserved ejection fraction. Jancin, Bruce Nov 1, 2014 390
Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018. Sep 29, 2014 829
Analyses of Pooled Data from Three Phase III Trials of Pirfenidone (Esbriet[,u-]) Show a Favourable and Persistent Treatment Benefit on Disease Progression in Patients with Idiopathic Pulmonary Fibrosis up to 72 weeks. Sep 9, 2014 2303
OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018. Sep 3, 2014 597
United Kingdom : GSK and Genmab announce positive interim result for phase III study of ofatumumab as maintenance therapy for relapsed CLL. Aug 1, 2014 354
Sanofi Reports Positive Phase 3 Results for Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL). Financial report Jun 14, 2014 2768
PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2). May 31, 2014 1551
PROCLAIM(SM) Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in Metastatic Renal Cell Carcinoma Patients Treated with High-Dose Interleukin-2 (HD IL-2). May 30, 2014 1916
Auxilium Pharmaceuticals, Inc. Presents New Analyses Of XIAFLEX Peyronie's Disease Data At Urology Meeting. May 19, 2014 2592
Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Safadi, Marco Aurelio Palazzi; Carvalhanas, Telma Regina Marques Pinto; de Lemos, Ana Paula; Gorla, Clinical report May 1, 2014 4350
Auxilium Pharmaceuticals, Inc. Announces Presentation Of Data For XIAFLEX At Urology Meeting. Apr 28, 2014 1467
SRI International Announces PDCellX(TM) Xenograft Tumor Model Services to Accelerate Cancer Drug Research. Apr 16, 2014 762
Oklahoma State University study reveals better method to test cats for heartworm infections. Clinical report Jan 13, 2014 1389
"Outdoor testing is the backbone of weathering testing": development of useful accelerated test methods relies on data produced in outdoor tests. Jan 1, 2014 376
"Outdoor Testing is the Backbone of Weathering Testing": development of useful accelerated test methods relies on data produced in outdoor tests. Jan 1, 2014 376
Restrictions pulled on GSK's Avandia. Dec 16, 2013 546
CTI Announces Data Presentations at the 55th American Society of Hematology Annual Meeting. Nov 7, 2013 1343
Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Gumede, Nicksy; Lentsoane, Olivia; Burns, Cara C.; Pallansch, Mark; de Gourville, Esther; Yogolelo, Oct 1, 2013 4417
Patricia A. English is recognized by Continental Who's Who as a Pinnacle Professional. Sep 26, 2013 385
Positive Results for D-Pharm's Investigational Drugs in Models of Human African Trypanosomiasis and Malaria. Aug 19, 2013 528
Positive Results for D-Pharm's Investigational Drugs in Models of Human African Trypanosomiasis and Malaria. Aug 19, 2013 530
Using common random numbers in health care cost-effectiveness simulation modeling. Murphy, Daniel R.; Klein, Robert W.; Smolen, Lee J.; Klein, Timothy M.; Roberts, Stephen D. Aug 1, 2013 5268
Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel. Weinberger, Daniel M.; Givon-Lavi, Noga; Shemer-Avni, Yonat; Bar-Ziv, Jacob; Alonso, Wladimir J.; Gr Jul 1, 2013 5416
Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma. Jun 16, 2013 1767
Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients. Feb 22, 2013 221
Patricia A. English is recognized by Continental Who's Who as a Pinnacle Professional. Feb 18, 2013 387
The role of adverse physical health events on the utilization of mental health services. Yoon, Jangho; Bernell, Stephanie L. Feb 1, 2013 7222
Cellular dynamics' iPSC-derived human cells to be used in drug discovery research. Jan 14, 2013 261
iCell Neurons Enable Alzheimer's Disease Modeling and Demonstrate Potential Use in High Throughput Screening at GlaxoSmithKline. Dec 12, 2012 676
AstraZeneca to Present Key New Data for Hormone Receptor-Positive Metastatic Breast Cancer at the 35th CTRC-AACR Annual San Antonio Breast Cancer Symposium. Dec 4, 2012 1709
Weight gain after diabetes diagnosis raises mortality. Zoler, Mitchel L. Nov 15, 2012 482
Weight gain after diabetes diagnosis is deadly. Zoler, Mitchel L. Nov 15, 2012 417
Linezolid bested vancomycin in MRSA pneumonia. Otto, M. Alexander Nov 15, 2012 236
Dr. Toufigh Gordi to Discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit. Nov 8, 2012 409
Novo Nordisk announces U.S. results of largest multinational psychosocial study of living with hemophilia. Clinical report Nov 7, 2012 1456
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. van Deursen, Anna M.M.; van Mens, Suzan P.; Sanders, Elisabeth A.M.; Vlaminckx, Bart J.M.; de Melker Clinical report Nov 1, 2012 7794
Modular construction considerations: the lean way to design and build pharmaceutical facilities. Gilroy, John; Martini, Gene Nov 1, 2012 1271
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa's Impact Webinar Series. Oct 10, 2012 645
Allotetraploids in patagonia with affinities to western North American diploids: did dispersal or genome doubling occur first? Johnson, Leigh A.; Chan, Lauren M.; Pozner, Raul; Glazier, Lisa D. Report Sep 1, 2012 7481
By satisfying patients a stronger care model can be built. Aug 27, 2012 659
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies. Aug 16, 2012 1101
Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC). Aug 10, 2012 1283
Novartis RAD001 with reduced tacrolimus provides similar efficacy, renal function to tacrolimus only. Clinical report Aug 1, 2012 195
Million workers on drugs. Jul 2, 2012 112
Effects of cannabinoids [DELTA](9)-tetrahydrocannabinol, [DELTA](9)-tetrahydrocannabinolic acid and cannabidiol in [MPP.sup.+] affected murine mesencephalic cultures. Moldzio, Rudolf; Pacher, Thomas; Krewenka, Christopher; Kranner, Barbara; Novak, Johannes; Duvigneau Jun 15, 2012 4303
Post Hoc Analysis Indicated That Timing And Magnitude Of Initial Response To Certolizumab Pegol Predicted Likelihood Of Low Disease Activity At Week 28 In Patients With Active Moderate To Severe Rheumatoid Arthritis. Clinical report Jun 8, 2012 3987
Tranzyme Pharma and Norgine BV announce top-line results of the primary analysis of ULISES 008, the second Phase 3 trial evaluating Ulimorelin. Financial report May 28, 2012 218
Codexis and Merck Develop Prototype Enzyme-Based Method for Production of Boceprevir. Apr 3, 2012 384
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012. Mar 10, 2012 362
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics. Jan 30, 2012 326
THE effects of anti-viral drug [...]. Jan 23, 2012 235
Judicial litigations and social welfare: access to medicines in two towns in the Santa Catarina State, Brazil/Judicializacao e assistencia social: formas de acesso a medicamentos em dois municipios no Estado de Santa Catarina, Brasil. Leite, Silvana Nair; Schaefer, Cristine; Fittkau, Kelly Jan 1, 2012 4257
CytRx begins Phase IIb study of INNO-206 in advanced soft tissue sarcoma. Dec 23, 2011 154
iderIdera Pharmaceuticals presents promising data on IMO-4200 in preclinical models of lymphoma. Dec 14, 2011 215
New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia (certolizumab pegol) at Week 12 was Predictive of Week 52 Response. Nov 7, 2011 3406
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting. Nov 5, 2011 2731
Merck's VICTRELIS shows positive interim results in Phase IIb study. Clinical report Oct 21, 2011 221
Conversation Continues Rapid Rise in the Agency World; Growth Brings Promotions and Optimizations in Fourth Quarter. Oct 17, 2011 595
Pfizer reports top-line results from study of VFEND, ERAXISTM combination therapy. Sep 30, 2011 212
Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment. Sep 22, 2011 945
Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs. Sep 22, 2011 662
Nonpsychiatrists fuel rise in antidepressant use. Hayes, Emily Sep 1, 2011 876
Nonpsychiatric use of antidepressants on rise. Hayes, Emily Sep 1, 2011 697
An inexpensive method of alleviating pain. Aug 8, 2011 498
Novartis' Afinitor extends PFS in Phase III study in women with advanced breast cancer. Jul 5, 2011 192
Canadian study eyes generic drugs' impact. Jun 6, 2011 379
Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study with Cimzia (certolizumab pegol). May 16, 2011 2633
Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. Agyare, Christian; Lechtenberg, Matthias; Deters, Alexandra; Petereit, Frank; Hensel, Andreas May 15, 2011 6713
Cimzia(R) (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients. May 10, 2011 1778
Cimzia (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients. May 10, 2011 2854
Community pharmacists benefit from effective advocate. Apr 25, 2011 297
Evolution of service model results in bigger health care role. Apr 25, 2011 241
Rosa Diabetes PhysioPD[TM] Collaboration with Pfizer to be Presented at World PK/PD Summit. Apr 23, 2011 381
MIT's Koch Institute to use Roche LightCycler 480 System to Help Advance Cancer Research. Apr 6, 2011 592
Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011. Mar 22, 2011 341
Sage Bionetworks Announces Cancer Partnership with AstraZeneca. Mar 18, 2011 433
Charles River to supply Pfizer's research models. Mar 1, 2011 256
Purdue University Researcher's Technology "Listens" to Cancer Cells, Shows Effects of Drug Therapies. Feb 9, 2011 443
A comparative chemical and pharmacological study of standardized extracts and vanillic acid from wild and cultivated Amburana cearensis A.C. Smith. Leal, L.k.A.M.; Pierdona, T.M.; Goes, J.G.S.; Fonseca, K.S.; Canuto, K.M.; Silveira, E.R.; Bezerra, Report Jan 15, 2011 2587
Women with advanced breast cancer who were treated with Roche Holding AG's (Basel CHE) Avastin were more likely to develop heart failure than other women, according to an analysis released last week that raised more concerns about the already troubled drug. Jan 10, 2011 346
Findings Published in Journal of Pharmacology and Experimental Therapeutics Demonstrate Potential for Amira Pharmaceuticals' LPA1 Receptor Antagonist as an Anti-Fibrotic Agent. Jan 5, 2011 401
Findings Published in Journal of Pharmacology and Experimental Therapeutics Demonstrate Potential for Amira Pharmaceuticals' LPA1 Receptor Antagonist as an Anti-Fibrotic Agent. Jan 5, 2011 388
Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis via a caspase-dependent pathway as compared to Ophiopogon japonicus lectin. Zhang, Zi-Ting; Peng, Hao; Li, Chun-Yang; Liu, Jun-Jie; Zhou, Ting-Ting; Yan, Yi-Fang; Li, Yan; Bao, Report Dec 15, 2010 4885
Study of Novartis' Zometa for potential use in early breast cancer fails to meet primary endpoint in overall study population. Dec 10, 2010 365
Novel agent effective in IBS with constipation: improvements reported in first week of therapy; decrease in abdominal pain demonstrated. Napoli, Denise Report Dec 1, 2010 691
Linaclotide effective for IBS with constipation. Napoli, Denise Clinical report Dec 1, 2010 593
Abbott evaluates relationship of physical function to inflammation, structural damage in RA. Clinical report Nov 9, 2010 322
Eli Lilly & Co (Indianapolis IN) and Merck KGaA's (Darmstadt DEU) Erbitux helped a group of cancer patients previously thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. Nov 1, 2010 349
With very low LDL, HDL is not a marker. Worcester, Sharon Aug 1, 2010 1189
Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Luo, Y.; Liu, M.; Xia, Y.; Dai, Y.; Chou, G.; Wang, Z. Report Aug 1, 2010 3989
FHI applies new technology. Aug 1, 2010 326
PCMA: New Generic Pharmaceutical Study Finds Savings of $824 Billion Over the Last Decade. Jul 27, 2010 262
Pharmaceutical, Biotech and Guidance Agencies including GlaxoSmithKline, Noven Pharmaceuticals Inc., Roche Carolina, Pfizer, Eli Lilly, Abbott and More Will Convene to Discuss the Latest in PAT & QbD Initiatives. Jul 21, 2010 363
EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's Disease. Jul 14, 2010 504
Topical NSAIDs safe in elderly osteoarthritis patients. Boschert, Sherry Jun 15, 2010 732
Afghanistan Drug Control: Strategy Evolving and Progress Reported, but Interim Performance Targets and Evaluation of Justice Reform Efforts Needed. Jun 1, 2010 914
Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra (Eplerenone). May 27, 2010 1210
Almac, Merck, MRC. May 1, 2010 156
ChronTech Pharma AB: ChronSeal[R] study completed and continuing positive results in the follow-up of the ChronVac-C[R]-study. Clinical report Apr 28, 2010 538
Majority of hepatitis C patients on Anadys' ANA598 achieve undetectable levels of virus in Phase II study. Apr 16, 2010 206
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Combination Study of MM-121 and Tarceva(R) in Patients with Non-Small Cell Lung Cancer. Feb 22, 2010 729
Sage Bionetworks forms oncology research collaboration with Pfizer. Jan 14, 2010 103
Sage Bionetworks Announces Oncology Research Partnership with Pfizer. Jan 11, 2010 355
Roche cuts short heart failure study. Dec 11, 2009 161
Plan improves Rx compliance. Brief article Dec 7, 2009 170
Report shines light on specialty meds. Dec 7, 2009 312
PCMA: Baucus Health Reform Plan Sustains Proven PBM Delivery Model Yielding Expanded Access, Lower Costs. Sep 16, 2009 232
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease. Jul 1, 2009 763
NICE Acknowledge Alzheimer's Model Faulty but do not Plan to Change Recommendations. Jun 10, 2009 862
PCMA: New National Generic Pharmaceutical Study Finds Savings of $734 Billion Over the Last Decade. May 7, 2009 340
Zoledronic acid boosts antitumor effects of chemotherapy. Wachter, Kerri Mar 1, 2009 684
Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells. Liu, H.J.; Wang, X.L.; Zhang, L.; Qiu, Y.; Li, T.J.; Li, R.; Wu, M.C.; Wei, L.X.; Rui, Y.C. Report Mar 1, 2009 4125
A study on the state of the biopharmaceutical sector in India with emphasis on its exports. Banerji, Amit Report Jan 1, 2009 6223
Safety is examined in study. Brief article Dec 8, 2008 201
Pregabalin can be effective addition for some seizures. Sullivan, Michele G. Dec 1, 2008 354
Pregabalin deemed safe add-on for refractory seizures. Sullivan, Michele G. Oct 1, 2008 420
Integrated optical microscope identifies features to 1.5 microns. May 1, 2008 103
Model's new look. Mar 13, 2008 242
'Plant-Bacteria Interactions: Strategies and Techniques to Promote Plant Growth' Now Available. Mar 7, 2008 392
CLSI Publishes Guideline for In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents. Mar 7, 2008 414
Examine the US Pharmaceutical Industry's Political, Economic, Social and Technological Issues With This PEST Framework Analysis. Mar 7, 2008 249
Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Delhaes, Laurence; Harun, Azian; Chen, Sharon C.A.; Nguyen, Quoc; Slavin, Monica; Heath, Christopher Feb 1, 2008 6162
Aureon Laboratories to Collaborate with Pfizer, Inc. to Establish Quantitative Biometrics for Assessing Therapeutic Response of Prostate Cancer Patients Treated with Hormone Therapy. Jan 22, 2008 338
The Study 'Combinatorial Materials Science' is a Compelling Resource for Graduate-Level Courses in Materials Science/Engineering, Polymer Science, Chemical Engineering, and Chemistry. Nov 22, 2007 522
New Phase III Trial Results for Rivaroxaban to be Presented at the 49th Annual Meeting of the American Society of Hematology. Nov 9, 2007 545
Post-Stroke Patients Treated with Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function. Nov 5, 2007 1154
New Lipitor Data Analyses from Landmark Ideal and SPARCL Trials to Be Presented at Upcoming Annual Scientific Sessions of the American Heart Association. Nov 4, 2007 601
Ligand Announces Positive Preclinical Data on Selective Androgen Receptor Modulator LGD-3303. Sep 17, 2007 685
Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show. Jul 25, 2007 660
Announcing IVT's 13th Annual International Validation Week. Jul 17, 2007 354
US Pharmaceutical Industry - PEST Framework Analysis. Jul 11, 2007 262
IVT Lab Week Event Combining Method Validation, Laboratory Compliance and Stability Testing. Jul 10, 2007 370
Pharmaceutical Strategies Group Welcomes New Talent in the Southeast. Jun 26, 2007 271
Everest Group to Present "Developing and Managing CRO Relationships" Webinar on June 27. Jun 18, 2007 326
CLSI Publishes Approved Guideline for Bacterial Strain Typing. May 30, 2007 308
Does bilirubin cause interference in Roche creatinine methods? Owen, Laura J.; Keevil, Brian G. Letter to the editor Feb 1, 2007 1017
454 Life Sciences and Max Planck publish sequence of one million base pairs of Neandertal DNA. Nov 1, 2006 726
First-ever Study to Quantify Societal Costs of Opioid Abuse; Analysis Group Finds Costs to the U.S. Total $9.6 Billion. Oct 16, 2006 369
Gain an Insight into the Financial Performance of the Major Players Operating in the US Pharmaceutical Industry. Aug 17, 2006 270
Simple in-office measures can improve elderly quality of life. Rollins, Jane Neff Jul 15, 2006 534
Personalized medicine will not destroy blockbuster model--Pfizer exec. Jun 1, 2006 323
Thermal analysis differential scanning calorimeter. May 1, 2006 107
Rare IgM interference with Roche/Hitachi Modular glucose and [gamma]-glutamyltransferase methods in heparin samples. Dimeski, Goce; Carter, Andrew Nov 1, 2005 1315
Analyzing the pharmaceutical industry through quantitative models. Russakoff, Andrew; Gould, James Sep 22, 2005 2813
Roche IFCC methods for lactate dehydrogenase tested for duplicate errors with Greiner and Becton-Dickinson lithium-heparin and Greiner serum samples. Dimeski, Goce; Badrick Tony; Flatman, Robert; Ormiston, Barry Dec 1, 2004 1292
Is there a biomedical anticommons? Patent holders have a strong interest in profiting from their patents. Epstein, Richard A.; Kuhlik, Bruce N. Jun 22, 2004 4149
Del Pharmaceuticals delivers on its promises. Jun 21, 2004 1055
Swedish report finds connection between marketing and medication sales. Brief Article May 18, 2004 204
Hazards of the FDA. Hoar, William P. Brief Article May 17, 2004 289
Trends in Medicaid prescribed drug expenditures and utilization. Tepper, Carl D.; Lied, Terry R. Mar 22, 2004 1617
Productivity. Mar 22, 2004 1538
An overview of drug development in the United States and current challenges. Moore, Sharon Wyatt Dec 1, 2003 8967
Biotech pivotal to product pipeline. (Prescription Drugs). May 19, 2003 382
Study spotlights high-growth items. (O-T-C Health Care). Industry Overview May 19, 2003 413
Analysts: prospects are improving for pharmaceutical industry. (RX/News). Apr 28, 2003 1819
Tracking trends in Rx care. (Focus). Jan 20, 2003 492
A Renewed Sense of Optimism Evident. Industry Overview Feb 28, 2000 780
The next front. Fetter, Marilyn S. Editorial Aug 1, 1998 1272
Pharmaceutical industry review and outlook. Abbas, Syed Ghayyur Industry Overview Jul 1, 1995 1016
World drug industry less hot in 1990s. Aug 1, 1990 502

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters